{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:32:40Z","timestamp":1774621960725,"version":"3.50.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,27]],"date-time":"2012-09-27T00:00:00Z","timestamp":1348704000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1472-6947-12-110","type":"journal-article","created":{"date-parts":[[2012,9,27]],"date-time":"2012-09-27T22:29:19Z","timestamp":1348784959000},"source":"Crossref","is-referenced-by-count":15,"title":["Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review"],"prefix":"10.1186","volume":"12","author":[{"given":"Amani Thomas","family":"Mori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bjarne","family":"Robberstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,27]]},"reference":[{"key":"544_CR1","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198529446.001.0001","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"MF Drummond","year":"2005","unstructured":"Drummond MF, Sculpher MJ, Torrance GW, O\u2019Brien BJ, Stoddart GL: Methods for the Economic Evaluation of Health Care Programmes. 2005, New York: Oxford University Press, 3","edition":"3"},{"key":"544_CR2","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s10198-003-0195-0","volume":"5","author":"A Anell","year":"2004","unstructured":"Anell A: Priority setting for pharmaceuticals; the use of health economic evidence by reimbursement and clinical guidance committees. Eur J Heal Econ. 2004, 5: 28-35. 10.1007\/s10198-003-0195-0.","journal-title":"Eur J Heal Econ"},{"key":"544_CR3","volume-title":"Guide to the methods of technology appraisal","author":"National Institute for Health and Clinical Excellence","year":"2008","unstructured":"National Institute for Health and Clinical Excellence: Guide to the methods of technology appraisal. 2008, London"},{"key":"544_CR4","volume-title":"Guidelines for the economic evaluation of health technologies","author":"CADTH","year":"2006","unstructured":"CADTH: Guidelines for the economic evaluation of health technologies. 2006, Ottawa, Canada: Canadian Agency for Drugs and Technologies in Health, 3","edition":"3"},{"issue":"suppl 1","key":"544_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2165\/00019053-199600091-00005","volume":"9","author":"LA Sanchez","year":"1996","unstructured":"Sanchez LA: Pharmacoeconomics and formulary decision-making. PharmacoEconomics. 1996, 9 (suppl 1): 16-25.","journal-title":"PharmacoEconomics"},{"issue":"12","key":"544_CR6","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.2165\/11584890-000000000-00000","volume":"28","author":"Z Babar","year":"2010","unstructured":"Babar Z, Scahill S: Is There a Role for Pharmacoeconomics in Developing Countries?. PharmacoEconomics. 2010, 28 (12): 1069-1074. 10.2165\/11584890-000000000-00000.","journal-title":"PharmacoEconomics"},{"issue":"1","key":"544_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2165\/11585790-000000000-00000","volume":"29","author":"AA Shafie","year":"2011","unstructured":"Shafie AA, Hassali MA: Is There a Role for Pharmacoeconomics in Developing Countries?. PharmacoEconomics. 2011, 29 (1): 83-86. 10.2165\/11585790-000000000-00000.","journal-title":"PharmacoEconomics"},{"key":"544_CR8","volume-title":"The use of essential drugs: report of a WHO expert committee. Technical report series no 895","author":"World Health Organization","year":"2000","unstructured":"World Health Organization: The use of essential drugs: report of a WHO expert committee. Technical report series no 895. 2000, Geneva"},{"key":"544_CR9","volume-title":"Primary health care: reportof the International onPrimary Health Care, Alma-Alta,USSR, September 6\u201312, 1978. Health for all, series 1","author":"WHO, UNESCO","year":"1978","unstructured":"WHO, UNESCO: Primary health care: reportof the International onPrimary Health Care, Alma-Alta,USSR, September 6\u201312, 1978. Health for all, series 1. 1978, Geneva"},{"key":"544_CR10","volume-title":"Medicine supply: lessons learnt in Tanzania and Mozambique","author":"K Wiedenmayer","year":"2004","unstructured":"Wiedenmayer K: Medicine supply: lessons learnt in Tanzania and Mozambique. 2004, Switzerland: Swiss Agency for Development and Cooperation (SDC)"},{"key":"544_CR11","volume-title":"Global Burden of Diseases; 2004 update","author":"World Health Organization","year":"2008","unstructured":"World Health Organization: Global Burden of Diseases; 2004 update. 2008, Geneva, Switzerland"},{"key":"544_CR12","volume-title":"The world medicine situation","author":"World Health Organization","year":"2011","unstructured":"World Health Organization: The world medicine situation. 2011, Geneva, Switzerland"},{"key":"544_CR13","volume-title":"Standard Treatment Guidelines and the National Essential Medicine List","author":"Ministry of Health and Social Welfare","year":"2007","unstructured":"Ministry of Health and Social Welfare: Standard Treatment Guidelines and the National Essential Medicine List. 2007, Dar es Salaam-Tanzania: The Government Press, 3","edition":"3"},{"key":"544_CR14","volume-title":"The selection and use of essential medicines. Report of the WHO Expert Committee, 2002 (including the 12th Model List of Essential Medicines)","author":"World Health Organization","year":"2003","unstructured":"World Health Organization: The selection and use of essential medicines. Report of the WHO Expert Committee, 2002 (including the 12th Model List of Essential Medicines). 2003, Geneva: Technical Report Series No. 914"},{"key":"544_CR15","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/978-0-387-78665-0_33","volume-title":"Handbook of Disease Burden (in press)","author":"B Robberstad","year":"2010","unstructured":"Robberstad B, Hemed Y: Economic Evaluations of Health Interventions: Tanzania Perspectives. Handbook of Disease Burden (in press). Edited by: Preedy VA. 2010, Heidelberg: Springer Verlag, 547-586."},{"key":"544_CR16","doi-asserted-by":"crossref","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group: Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Medicine. 2009, 6 (7):","DOI":"10.1371\/journal.pmed.1000097"},{"key":"544_CR17","volume-title":"International Journal of Gynecology and Obstetrics","author":"HL Kidanto","year":"2006","unstructured":"Kidanto HL, Kaguta MM, van Roosmalen J: Induction of labor with misoprostol or oxytocin in Tanzania: Brief communications. International Journal of Gynecology and Obstetrics. 2006, 30:"},{"issue":"Supp 2","key":"544_CR18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4269\/ajtmh.2006.75.131","volume":"75","author":"F Tediosi","year":"2006","unstructured":"Tediosi F, Hutton G, Maire N, Smith TA, Ross A, Tanner M: Predicting the cost-effectiveness of introducing a pre-erythrocytic malaria vaccine into expanded program on immunization in Tanzania. AmJTrop Med Hyg. 2006, 75 (Supp 2): 131-143.","journal-title":"AmJTrop Med Hyg"},{"key":"544_CR19","doi-asserted-by":"crossref","unstructured":"Conteh L, Sicuri E, Manzi F, Hutton G, Obonyo B, Tediosi F, Biao P, Masika P, Matovu F, Otieno P, Gosling RD, Hamel M, Odhiambo FO, Grobusch MP, Kremsner PG, Chandramohan D, Aponte JJ, Egan A, Schellenberg D, Macete E, Slutsker L, Newman RD, Alonso P, Mene\u2019ndez C, Tanner M: The Cost-Effectiveness of Intermittent PreventiveTreatment for Malaria in Infants in Sub-Saharan Africa. PLoS One. 2010, 5 (6):","DOI":"10.1371\/journal.pone.0010313"},{"key":"544_CR20","doi-asserted-by":"crossref","unstructured":"Guerriero C, Cairns J, Perel P, Shakur H, Roberts I: Cost-Effectiveness Analysis of Administering Tranexamic Acid to Bleeding Trauma Patients Using Evidence from the CRASH-2 Trial. PLoS One. 2011, 6 (5):","DOI":"10.1371\/journal.pone.0018987"},{"key":"544_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/QAI.0b013e3181eef4d3","volume":"55","author":"B Robberstad","year":"2010","unstructured":"Robberstad B, Olsen BE: Preventing Mother to Child Transmission of HIV With Highly Active Antiretroviral Treatment in Tanzania\u2014a Prospective Cost-Effectiveness Study. Journal of Acquired Immune Deficiency Syndrome. 2010, 55: 397-403. 10.1097\/QAI.0b013e3181eef4d3.","journal-title":"Journal of Acquired Immune Deficiency Syndrome"},{"key":"544_CR22","doi-asserted-by":"crossref","unstructured":"Robberstad B, Hemed Y, Norheim OF: Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country \u2013 the case of Tanzania. Cost Effectiveness and Resource Allocation. 2007, 5 (3):","DOI":"10.1186\/1478-7547-5-3"},{"key":"544_CR23","first-page":"523","volume":"82","author":"B Robberstad","year":"2004","unstructured":"Robberstad B, Strand T, Black RE, Sommerfelt H: Cost-effectiveness of zinc as adjunct therapy for acute childhood diarrhoea in developing countries. Bulletin of the World Health Organization. 2004, 82: 523-531.","journal-title":"Bulletin of the World Health Organization"},{"key":"544_CR24","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1097\/01.aids.0000131353.06784.8f","volume":"18","author":"MD Sweat","year":"2004","unstructured":"Sweat MD, O\u2019Reilly KR, Schmid GP, Denison J, de Zoysab I: Cost-effectiveness of nevirapine to prevent mother-tochild HIV transmission in eight African countries. AIDS. 2004, 18: 1661-1671. 10.1097\/01.aids.0000131353.06784.8f.","journal-title":"AIDS"},{"key":"544_CR25","volume-title":"The costs, effects and cost-effectiveness of changing the first line drug for treatment of malaria in Tanzania","author":"S Abdulla","year":"2000","unstructured":"Abdulla S, Goodman C, Coleman P, Mubyazi G, Kikumbih N, Okorosobo T: The costs, effects and cost-effectiveness of changing the first line drug for treatment of malaria in Tanzania. 2000, Health Economics and Financing Program, Working Paper 01\/00; Dar es Salaam"},{"key":"544_CR26","doi-asserted-by":"crossref","unstructured":"Wiseman V, Kim M, Mutabingwa TK, Whitty CJ: Cost-Effectiveness Study of Three Antimalarial Drug Combinations in Tanzania. PLoS Medicine. 2006, 3 (10):","DOI":"10.1371\/journal.pmed.0030373"},{"key":"544_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2471\/BLT.08.051961","volume":"87","author":"G Hutton","year":"2009","unstructured":"Hutton G, Schellenberg D, Tediosi F, Macete E, Kahigwa E, Sigauque B, Mas X, Trapero M, Tanner M, Trilla , Alonso P, Menendez C: Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania. Bulletin of the World Health Organization. 2009, 87: 123-129. 10.2471\/BLT.08.051961.","journal-title":"Bulletin of the World Health Organization"},{"issue":"1","key":"544_CR28","first-page":"97","volume":"78","author":"MA Gonzalez","year":"2000","unstructured":"Gonzalez MA, Menendez C, Font F, Kahigwa E, Kimario J, Mshinda H, Tanner M, Capblanch XB, Alonso PL: Cost-effectiveness of Iron supplementation and malaria chemoprophylaxis in the prevention of anaemia and malaria among Tanzanian infants. Bulletin of the World Health Organization. 2000, 78 (1): 97-107.","journal-title":"Bulletin of the World Health Organization"},{"key":"544_CR29","doi-asserted-by":"crossref","unstructured":"Guerriero C, Cairns J, Jayaraman S, Roberts I, Perel P, Shakur H: Giving tranexamic acid to reduce surgical bleeding in sub-Saharan Africa: an economic evaluation. Cost Effectiveness and Resource Allocation. 2010, 8 (1):","DOI":"10.1186\/1478-7547-8-1"},{"key":"544_CR30","doi-asserted-by":"publisher","first-page":"7167","DOI":"10.1016\/j.vaccine.2009.09.027","volume":"27","author":"E Shim","year":"2009","unstructured":"Shim E, Hampson K, Cleaveland S, Galvania AP: Evaluating the cost-effectiveness of rabies post-exposure prophylaxis: A case study in Tanzania. Vaccine. 2009, 27: 7167-7172. 10.1016\/j.vaccine.2009.09.027.","journal-title":"Vaccine"},{"issue":"8778","key":"544_CR31","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/0140-6736(91)92600-7","volume":"338","author":"CJ Murray","year":"1991","unstructured":"Murray CJ, DeJonghe E, Chum HJ, Nyangulu DS, Salomao A, Styblo K: Cost effectiveness of chemotherapy for pulmonary tuberculosis in three sub-Saharan African countries. Lancet. 1991, 338 (8778): 1305-1308. 10.1016\/0140-6736(91)92600-7.","journal-title":"Lancet"},{"issue":"9700","key":"544_CR32","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/S0140-6736(09)61258-7","volume":"374","author":"J Aponte","year":"2009","unstructured":"Aponte J, Schellenberg D, Egan A, Breckenridge A, Carneiro I, Critchley J, Danquah I, Dodoo A, Kobbe R, Lell B, May J, Premji Z, Sanz S, Sevene E, Soulaymani-Becheikh R, Winstanley P, Adjei S, Anemana S, Chandramohan D, Issifou S, Mockenhaupt F, Owusu-Agyei S, Greenwood B, Grobusch MP, Kremsner PG, Macete E, Mshinda H, Newman RD, Slutsker L, Tanner M: Efficacy and Safety of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine for Malaria in African Infants: A Pooled Analysis of Six Randomised, Placebo-Controlled Trials. Lancet. 2009, 374 (9700): 1533-1542. 10.1016\/S0140-6736(09)61258-7.","journal-title":"Lancet"},{"key":"544_CR33","doi-asserted-by":"crossref","unstructured":"Henry DA, Carless PA, Moxey AJ, O\u2019Connell D, Stoke BJ, McClelland B, Laupacis A, Fergusson D: Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database of Systematic Reviews. 2007, CD001886-4","DOI":"10.1002\/14651858.CD001886.pub2"},{"issue":"9771","key":"544_CR34","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/S0140-6736(11)60317-6","volume":"377","author":"I Roberts","year":"2011","unstructured":"Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T, CRASH-2 collaborators: The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011, 377 (9771): 1096-1101.","journal-title":"Lancet"},{"key":"544_CR35","volume-title":"World Health Report 2002","author":"World Health Organization","year":"2002","unstructured":"World Health Organization: World Health Report 2002. 2002, Geneva"},{"key":"544_CR36","volume-title":"World Economic Outlook Database","author":"International Monetary Fund","year":"2011","unstructured":"International Monetary Fund: World Economic Outlook Database. 2011, Washington DC"},{"key":"544_CR37","volume-title":"Health Sector Performance Profile Report 2010 Update","author":"Ministry of Health and Social Welfare","year":"2011","unstructured":"Ministry of Health and Social Welfare: Health Sector Performance Profile Report 2010 Update. 2011, Dar es Salaam"},{"key":"544_CR38","volume-title":"Macroeconomics and health: Investing in health for economic development","author":"Commission on Macroeconomics and Health","year":"2001","unstructured":"Commission on Macroeconomics and Health: Macroeconomics and health: Investing in health for economic development. 2001, Geneva"},{"key":"544_CR39","doi-asserted-by":"crossref","unstructured":"Young F, Critchley JA, Johnstone LK, Unwin NC: A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and Diabetes Mellitus, HIV and Metabolic Syndrome, and the impact of globalization. Glob Heal. 2009, 5 (9):","DOI":"10.1186\/1744-8603-5-9"},{"key":"544_CR40","volume-title":"AMMP Final Report-The Policy Implications of Tanzania Mortality Burden; A 10 year Community-Based Perspective","author":"Adult Mortality and Morbidity Project","year":"2004","unstructured":"Adult Mortality and Morbidity Project: AMMP Final Report-The Policy Implications of Tanzania Mortality Burden; A 10 year Community-Based Perspective. 2004, Dar es Salaam"},{"key":"544_CR41","volume-title":"Annual Health Statistical Abstract","author":"Department of Policy and Planning","year":"2008","unstructured":"Department of Policy and Planning: Annual Health Statistical Abstract. 2008, Dar es Salaam"},{"key":"544_CR42","volume-title":"Rapid Advice: Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants","author":"World Health Organization","year":"2009","unstructured":"World Health Organization: Rapid Advice: Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. 2009, Geneva"},{"key":"544_CR43","volume-title":"Guide on Prevention of Mother to Child Transmission-Updates","author":"Ministry of Health and Social Welfare","year":"2011","unstructured":"Ministry of Health and Social Welfare: Guide on Prevention of Mother to Child Transmission-Updates. 2011, Dar es Salaam"},{"key":"544_CR44","volume-title":"Transaction prices for antiretroviral medicines and HIV diagnostics from 2008 to July 2011: global price reporting mechanism, GPRM, October 2011","author":"World Health Organization","year":"2011","unstructured":"World Health Organization: Transaction prices for antiretroviral medicines and HIV diagnostics from 2008 to July 2011: global price reporting mechanism, GPRM, October 2011. 2011, Geneva"},{"key":"544_CR45","volume-title":"Programmatic update: Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants","author":"World Health Organization","year":"2012","unstructured":"World Health Organization: Programmatic update: Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. 2012, Geneva"},{"issue":"4","key":"544_CR46","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1128\/CMR.17.4.760-769.2004","volume":"17","author":"HL Guyatt","year":"2004","unstructured":"Guyatt HL, Snow RW: Impact of Malaria during Pregnancy on Low Birth Weight in Sub-Saharan Africa. Clin Microbiol Rev. 2004, 17 (4): 760-769. 10.1128\/CMR.17.4.760-769.2004.","journal-title":"Clin Microbiol Rev"},{"key":"544_CR47","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1056\/NEJM198501103120204","volume":"312","author":"MC McCormick","year":"1985","unstructured":"McCormick MC: The contribution of low birth weight to infant mortality and childhood mortality. N Engl J Med. 1985, 312: 82-90. 10.1056\/NEJM198501103120204.","journal-title":"N Engl J Med"},{"issue":"9814","key":"544_CR48","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(12)60034-8","volume":"379","author":"JL Murray","year":"2012","unstructured":"Murray JL, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD: Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet. 2012, 379 (9814): 413-431. 10.1016\/S0140-6736(12)60034-8.","journal-title":"Lancet"},{"key":"544_CR49","volume-title":"National Guidelines for Malaria Diagnosis and Treatment","author":"National Malaria Control Programme","year":"2000","unstructured":"National Malaria Control Programme: National Guidelines for Malaria Diagnosis and Treatment. 2000, Dar es Salaam"},{"key":"544_CR50","volume-title":"National Guidelines for Malaria Diagnosis and Treatment","author":"National Malaria Control Programme","year":"2006","unstructured":"National Malaria Control Programme: National Guidelines for Malaria Diagnosis and Treatment. 2006, Dar es Salaam"},{"key":"544_CR51","doi-asserted-by":"crossref","unstructured":"Mori AT, Kaale EA: Priority setting for the implementation of artemisinin-based combination therapy policy in Tanzania: Evaluation against the accountability for reasonableness framework. Implement Sci. 2012, 7 (18):","DOI":"10.1186\/1748-5908-7-18"},{"key":"544_CR52","volume-title":"WHO Policy recommendation on Intermittent Preventive Treatment during infancy with sulphadoxine-pyrimethamine (SP-IPTi) for Plasmodium falciparum malaria control in Africa","author":"World Health Organization","year":"2010","unstructured":"World Health Organization: WHO Policy recommendation on Intermittent Preventive Treatment during infancy with sulphadoxine-pyrimethamine (SP-IPTi) for Plasmodium falciparum malaria control in Africa. 2010, Geneva"},{"key":"544_CR53","volume-title":"Intermittent preventive treatment for infants using sulphadoxine-pyrimethamine (SP-IPTi) for malaria control in Africa: Implementation Field Guide","author":"World Health Organization","year":"2011","unstructured":"World Health Organization: Intermittent preventive treatment for infants using sulphadoxine-pyrimethamine (SP-IPTi) for malaria control in Africa: Implementation Field Guide. 2011, Geneva"},{"key":"544_CR54","doi-asserted-by":"crossref","unstructured":"Cairns M, Gosling R, Carneiro I, Gesase S, Mosha JF, Hashim R, Kaur H, Lemnge M, Mosha FW, Greenwood B, Chandramohan D: Duration of Protection Against Clinical Malaria Provided by Three Regimens of Intermittent Preventive Treatment in Tanzanian Infants. PLoS One. 2010, 5 (3):","DOI":"10.1371\/journal.pone.0009467"},{"key":"544_CR55","doi-asserted-by":"crossref","unstructured":"Schellenberg J, Maokola W, Shirima K, Manzi F, Mrisho M, Mushi A, Alonso P, Mshinda H, Tanner M, Schellenberg DM: Cluster-randomized study of intermittent preventive treatment for malaria in infants (IPTi) in southern Tanzania: evaluation of impact on survival. Malar J. 2011, 10 (387):","DOI":"10.1186\/1475-2875-10-387"},{"key":"544_CR56","volume-title":"Fact sheet N\u00b0330","author":"World Health Organization","year":"2009","unstructured":"World Health Organization: Diarrhoeal Diseases. Fact sheet N\u00b0330. 2009, Geneva"},{"key":"544_CR57","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/ajcn\/72.6.1516","volume":"72","author":"Zinc Investigators\u2019 Collaborative Group","year":"2000","unstructured":"Zinc Investigators\u2019 Collaborative Group: Therapeutic effects of oral zinc in acute and persistent diarrhoea in children in developing countries: pooled analysis of randomized controlled trials. Am J Clin Nutr. 2000, 72: 1516-1522.","journal-title":"Am J Clin Nutr"},{"key":"544_CR58","volume-title":"Why Children Are Dying and What Can Be Done","author":"The United Nations Children\u2019s Fund\/World Health Organization","year":"2009","unstructured":"The United Nations Children\u2019s Fund\/World Health Organization: Why Children Are Dying and What Can Be Done. 2009, New York"},{"key":"544_CR59","volume-title":"Joint Statement on Clinical Management of Acute Diarrhoea","author":"The United Nations Children\u2019s Fund\/World Health Organization","year":"2004","unstructured":"The United Nations Children\u2019s Fund\/World Health Organization: Joint Statement on Clinical Management of Acute Diarrhoea. 2004, New York"},{"key":"544_CR60","volume-title":"Application for the Inclusion of Zinc Sulfate in the WHO Model List of Essential Medicines","author":"WHO-Child and Adolescent Health Department","year":"2005","unstructured":"WHO-Child and Adolescent Health Department: Application for the Inclusion of Zinc Sulfate in the WHO Model List of Essential Medicines. 2005, Geneva"},{"key":"544_CR61","volume-title":"Introducing Improved Treatment of Diarrhoea with Zinc and ORT in Tanzania: A Public-Private Partnership Supported by the POUZN\/AED Project","author":"POUZN Project","year":"2010","unstructured":"POUZN Project: Introducing Improved Treatment of Diarrhoea with Zinc and ORT in Tanzania: A Public-Private Partnership Supported by the POUZN\/AED Project. 2010, Washington, DC: Point-of-Use Water Disinfection and Zinc Treatment (POUZN) Project, AED"},{"key":"544_CR62","volume-title":"National Package of Essential Health Interventions in Tanzania","author":"Ministry of Health","year":"2000","unstructured":"Ministry of Health: National Package of Essential Health Interventions in Tanzania. 2000, Dar es Salaam"},{"key":"544_CR63","volume-title":"Global Database on Blood Safety: Summary Report 1998\u20131999","author":"World Health Organization","year":"2004","unstructured":"World Health Organization: Global Database on Blood Safety: Summary Report 1998\u20131999. 2004, Geneva"},{"issue":"6","key":"544_CR64","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.2165\/00003495-199957060-00017","volume":"57","author":"CJ Dunn","year":"1999","unstructured":"Dunn CJ, Goa KL: Tranexamic acid: a review of its use in surgery and other indications. Drugs. 1999, 57 (6): 1005-1032. 10.2165\/00003495-199957060-00017.","journal-title":"Drugs"},{"key":"544_CR65","volume-title":"Summary of the report of the 18th meeting of the WHO Expert Committee on the Selection and Use of Essential Medicines, Accra-Ghana, 21\u201325 March 2011","author":"World Health Organization","year":"2011","unstructured":"World Health Organization: Summary of the report of the 18th meeting of the WHO Expert Committee on the Selection and Use of Essential Medicines, Accra-Ghana, 21\u201325 March 2011. 2011, Geneva"},{"key":"544_CR66","volume-title":"The National Tuberculosis\/Leprosy Program in Tanzania","author":"K Styblo","year":"1988","unstructured":"Styblo K: The National Tuberculosis\/Leprosy Program in Tanzania. 1988, World Health Organization, Geneva"},{"key":"544_CR67","first-page":"304","volume":"80","author":"S Cleaveland","year":"2002","unstructured":"Cleaveland S, Fe\u2019 vre EM, Kaare M, Coleman PG: Estimating human rabies mortality in the United Republic of Tanzania from dog bite injuries. Bulletin of the World Health Organization. 2002, 80: 304-310.","journal-title":"Bulletin of the World Health Organization"},{"issue":"49)","key":"544_CR68","first-page":"1","volume":"8","author":"MJ Sculpher","year":"2004","unstructured":"Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A: Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technology Assessment. 2004, 8 (49)): 1-192. iii-iv","journal-title":"Health Technology Assessment"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6947-12-110\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-12-110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-12-110","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-12-110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T21:23:56Z","timestamp":1714425836000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/1472-6947-12-110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,27]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["544"],"URL":"https:\/\/doi.org\/10.1186\/1472-6947-12-110","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,27]]},"article-number":"110"}}